Personal Information
Entreprise/Lieu de travail
Greater Boston Area United States
Profession
Assoc. Director, Drug substances
À propos
- Ph.D. in synthetic organic chemistry, B.S. in chemical engineering.
- 15 years of pharma/biotech industry experience in both drug discovery and development settings.
- A goal-oriented problem-solver with a proven track record of implementing robust, safe, and economical solutions to challenging chemical problems.
Mots-clés
fviii
hemophilia a
bla
novoeight
fda
inhibitor
hiv
integrase
discovery
raltegravir
drug
Tout plus
Présentations
(2)J’aime
(24)Hit2Lead by example: checkpoint kinase inhibitors
Vladimir Chupakhin
•
il y a 13 ans
Stability Of Carbon 14 Labelled Compounds
seankitson
•
il y a 12 ans
A Lifecycle Approach to Process Validation
Institute of Validation Technology
•
il y a 11 ans
The development & approval of Novoeight, a case study
Allen Che
•
il y a 9 ans
Part 4: New HIV Treatment Pipeline
NAPWA
•
il y a 15 ans
BioEntrepreneurship: Intellectual Property: What Do Investors Look For?
MaRS Discovery District
•
il y a 16 ans
Towards Personalized Medicine
Michel Dumontier
•
il y a 15 ans
Business Models For Biotech Firms
Alberto Onetti
•
il y a 15 ans
BioEntrepreneurship: The Business of Biotech
MaRS Discovery District
•
il y a 16 ans
Considerations On Biotech And Medtech Fundraising
EstherMM
•
il y a 15 ans
The Drug Development Process Kerentech
EstherMM
•
il y a 15 ans
Optimizing Preclinical Proof of Concept
MaRS Discovery District
•
il y a 15 ans
Canada - China Bio/Pharma Bridge
peterloorits
•
il y a 14 ans
Messages and drug master files in hospital e-prescription
Simon Letellier
•
il y a 17 ans
Drug Master Files for FDA/CDER
bergerb2
•
il y a 17 ans
Toxicology in Drug Development
MaRS Discovery District
•
il y a 16 ans
GMP AND cGMP CONSIDERATIONS
Prof. Dr. Basavaraj Nanjwade
•
il y a 15 ans
How to Draft a Patent
MaRS Discovery District
•
il y a 14 ans
Traditional Chinese Medicine
Fieldgarodie
•
il y a 15 ans
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional Medicines
Prof. Dr. Basavaraj Nanjwade
•
il y a 15 ans
Drug Discovery New Drug Development Process
Prof. Dr. Basavaraj Nanjwade
•
il y a 15 ans
Business Butterflies: The Power Of Social Media
Lara McCulloch-Carter
•
il y a 14 ans
Drug Discovery - The Origin of New Chemical Entity Pharmaceuticals
MaRS Discovery District
•
il y a 16 ans
Introduction To Drug Discovery
ubio Biotechnology Systems Pvt Ltd
•
il y a 16 ans
Personal Information
Entreprise/Lieu de travail
Greater Boston Area United States
Profession
Assoc. Director, Drug substances
À propos
- Ph.D. in synthetic organic chemistry, B.S. in chemical engineering.
- 15 years of pharma/biotech industry experience in both drug discovery and development settings.
- A goal-oriented problem-solver with a proven track record of implementing robust, safe, and economical solutions to challenging chemical problems.
Mots-clés
fviii
hemophilia a
bla
novoeight
fda
inhibitor
hiv
integrase
discovery
raltegravir
drug
Tout plus